treatment allocation NLCS, Incidence, Hughes, 2012 Case Cohort, 541/ Cancer registry colorectal 1.59 (1.23-2.06) Gene-interaction COL40943 Age: 55-69 4 654 and pathology Q 4 vs Q 1 Sex, ethnicity cancer, braf Ptrend:0.009 data Netherlands years, 7.3 database wildtype M/W MCCS, Incidence, Hughes, 2012 Prospective Cancer registry 480/ colorectal 1.66 (1.27-2.18) Gene-interaction COL40944 Cohort, and National . Q 4 vs Q 1 Sex, ethnicity 40 154 cancer, braf Ptrend:<0.001 data Australia Age: 27-75 Death index wildtype M/W high vs low (by criteria of 438 case/ Incidence, International Aleksandrova, 364 controls 1.68 (1.31-2.15) cancer Diabetes 2011 9.3 years Federation COL40878 EPIC, (IDF)) Denmark, Nested Case Cancer registry France, Control, high vs low and pathology Germany, Age: 25-70 (by criteria of register National Greece, years, Cholesterol Netherlands, M/W 231 cases/ Incidence, colon Education 1.55 (1.19-2.02) Spain, Sweden, 175 controls cancer UK Treatment Panel III (NCEP/ATPIII))
treatment allocation Hughes, 2012 COL40943 Netherlands NLCS, Case Cohort, Age: 55-69 years, M/W 541/ 4 654 7.3 Cancer registry and pathology database Incidence, colorectal cancer, braf wildtype Q 4 vs Q 1 1.59 (1.23-2.06) Ptrend:0.009 Sex, ethnicity Gene-interaction data Hughes, 2012 COL40944 Australia MCCS, Prospective Cohort, Age: 27-75 M/W 480/ 40 154 Cancer registry and National Death index . Incidence, colorectal cancer, braf wildtype Q 4 vs Q 1 1.66 (1.27-2.18) Ptrend:<0.001 Sex, ethnicity Gene-interaction data Aleksandrova, 2011 COL40878 Denmark, France, Germany, Greece, Netherlands, Spain, Sweden, UK EPIC, Nested Case Control, Age: 25-70 years, M/W 438 case/ 364 controls 9.3 years Cancer registry and pathology register Incidence, cancer high vs low (by criteria of International Diabetes Federation (IDF)) 1.68 (1.31-2.15) 231 cases/ 175 controls Incidence, colon cancer high vs low (by criteria of National Cholesterol Education Treatment Panel III (NCEP/ATPIII)) 1.55 (1.19-2.02)
CUP_colorectal_SLR_2016_RO.docx